盐酸甲氧氯普胺结构式
|
常用名 | 盐酸甲氧氯普胺 | 英文名 | metoclopramide hydrochloride |
|---|---|---|---|---|
| CAS号 | 54143-57-6 | 分子量 | 354.27 | |
| 密度 | N/A | 沸点 | 418.7ºC at 760mmHg | |
| 分子式 | C14H25Cl2N3O3 | 熔点 | N/A | |
| MSDS | 中文版 美版 | 闪点 | 207ºC | |
| 符号 |
GHS07 |
信号词 | Warning |
盐酸甲氧氯普胺用途Metoclopramide盐酸水合物是多巴胺受体D2拮抗剂。 |
| 中文名 | 盐酸胃复安 |
|---|---|
| 英文名 | metoclopramide hydrochloride |
| 中文别名 | 甲氧氯普胺盐酸盐 | 盐酸甲氧氯普胺 | 盐酸甲氧氯普胺 | N-[(2-二乙氨基)乙基]-4-氨基-2-甲氧基-5-氯-苯甲酰胺盐酸盐 |
| 英文别名 | 更多 |
| 沸点 | 418.7ºC at 760mmHg |
|---|---|
| 分子式 | C14H25Cl2N3O3 |
| 分子量 | 354.27 |
| 闪点 | 207ºC |
| PSA | 67.59000 |
| LogP | 3.77650 |
| InChIKey | KJBLQGHJOCAOJP-UHFFFAOYSA-N |
| SMILES | CCN(CC)CCNC(=O)c1cc(Cl)c(N)cc1OC.Cl.O |
| 储存条件 | 室温,干燥 |
| 符号 |
GHS07 |
|---|---|
| 信号词 | Warning |
| 危害声明 | H302-H315-H319-H335 |
| 警示性声明 | P301 + P312 + P330-P305 + P351 + P338 |
| 危险品运输编码 | NONH for all modes of transport |
|
Utility of cerebrospinal fluid drug concentration as a surrogate for unbound brain concentration in nonhuman primates.
Drug Metab. Pharmacokinet. 29(5) , 419-26, (2014) In central nervous system drug discovery, cerebrospinal fluid (CSF) drug concentration (C(CSF)) has been widely used as a surrogate for unbound brain concentrations (C(u,brain)). However, previous rod... |
|
|
Clinical challenge. Esophageal hiatal hernia.
J. Zoo Wildl. Med. 45(4) , 999-1001, (2014)
|
|
|
The relation between symptom improvement and gastric emptying in the treatment of diabetic and idiopathic gastroparesis.
Am. J. Gastroenterol. 108(9) , 1382-91, (2013) The relationship between symptom improvement (SI) and acceleration of gastric emptying (GE) for different drugs used in the treatment of idiopathic and diabetic gastroparesis is uncertain. In this pap... |
| Benzamide, 4-amino-5-chloro-N-(2-(diethylamino)ethyl)-2-methoxy-, monohydrochloride (9CI) |
| Annavar |
| 4-Amino-5-chloro-N-(2-(diethylamino)ethyl)-2-methoxybenzamide monohydrochloride |
| 4-amino-5-chloro-N-[2-(diethylamino)ethyl]-2-methoxybenzamide monohydrochloride |
| Benzamide, 4-amino-5-chloro-N-[2-(diethylamino)ethyl]-2-methoxy-, hydrochloride (1:1) |
| 4-Amino-5-chloro-N-[2-(diethylamino)ethyl]-2-methoxybenzamide hydrochloride (1:1) |
| Metoclopramide hydrochloride [USAN:JAN] |
| 4-Amino-5-chlor-N-[2-(diethylamino)ethyl]-2-methoxybenzolcarboxamidhydrochlorid |
| o-Anisamide, 4-amino-5-chloro-N-[2- (diethylamino)ethyl]-, monohydrochloride |
| GastreseL.A |
| 4-amino-5-chloro-N-[2-(diéthylamino)éthyl]-2-méthoxybenzamide chlorhydrate |
| Benzamide, 4-amino-5-chloro-N-[2- (diethylamino)ethyl]-2-methoxy-, monohydrochloride |
| Metoclopramide Hydrochloride (500 mg) |
| 4-Amino-5-chloro-N-[2-(diethylamino)ethyl]-o-anisamide hydrochloride |
| MFCD00150634 |
| benzamide, 4-amino-5-chloro-N-[2-(diethylamino)ethyl]-2-methoxy-, monohydrochloride |
| METOCLOPRAMIDEHYDROCHLORIDE,MONOHYDRATE,USP |
| MetoclopraMide HCI |
| Gastromax |
| 4-amino-5-chloro-N-[2-(diethylamino)ethyl]-2-methoxybenzamide hydrochloride |
| metoclopramide monohydrochloride |
| Gastrobidcontinus |
| EINECS 230-634-5 |
| MetoclopraMide Hydrochloride,USP |
| Metoclopramide hydrochloride |
| 4-Amino-5-chloro-N-(2-(diethylamino)ethyl)-o-anisamide hydrochloride |
| Metoclopramide (hydrochloride hydrate) |